Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease

A. Garcia-Gomez; D. Quwaider; M. Canavese; E.M. Ocio; Z. Tian; J.F. Blanco; A.J. Berger; C. Ortiz-de-Solorzano; T. Hernandez-Iglesias; A.C.M. Martens; R.W.J. Groen; J. Mateo-Urdiales; S. Fraile; M. Galarraga; D. Chauhan; J.F. San Miguel; N. Raje; M. Garayoa

doi:10.1158/1078-0432.CCR-13-1657

Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease

A. Garcia-Gomez, D. Quwaider, M. Canavese, E.M. Ocio, Z. Tian, J.F. Blanco, A.J. Berger, C. Ortiz-de-Solorzano, T. Hernandez-Iglesias, A.C.M. Martens, R.W.J. Groen, J. Mateo-Urdiales, S. Fraile, M. Galarraga, D. Chauhan, J.F. San Miguel, N. Raje, M. Garayoa

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1542-1554
Number of pages	13
Journal	Clinical Cancer Research
Volume	20
Issue number	6
DOIs	https://doi.org/10.1158/1078-0432.CCR-13-1657
Publication status	Published - 2014

Access to Document

10.1158/1078-0432.CCR-13-1657

http://clincancerres.aacrjournals.org/content/20/6/1542.long

Cite this

Garcia-Gomez, A., Quwaider, D., Canavese, M., Ocio, E. M., Tian, Z., Blanco, J. F., Berger, A. J., Ortiz-de-Solorzano, C., Hernandez-Iglesias, T., Martens, A. C. M., Groen, R. W. J., Mateo-Urdiales, J., Fraile, S., Galarraga, M., Chauhan, D., San Miguel, J. F., Raje, N., & Garayoa, M. (2014). Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease. Clinical Cancer Research, 20(6), 1542-1554. https://doi.org/10.1158/1078-0432.CCR-13-1657

@article{c99d29865a774f3986e6a54f57792901,

title = "Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease",

author = "A. Garcia-Gomez and D. Quwaider and M. Canavese and E.M. Ocio and Z. Tian and J.F. Blanco and A.J. Berger and C. Ortiz-de-Solorzano and T. Hernandez-Iglesias and A.C.M. Martens and R.W.J. Groen and J. Mateo-Urdiales and S. Fraile and M. Galarraga and D. Chauhan and {San Miguel}, J.F. and N. Raje and M. Garayoa",

year = "2014",

doi = "10.1158/1078-0432.CCR-13-1657",

language = "English",

volume = "20",

pages = "1542--1554",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "6",

}

Garcia-Gomez, A, Quwaider, D, Canavese, M, Ocio, EM, Tian, Z, Blanco, JF, Berger, AJ, Ortiz-de-Solorzano, C, Hernandez-Iglesias, T, Martens, ACM, Groen, RWJ, Mateo-Urdiales, J, Fraile, S, Galarraga, M, Chauhan, D, San Miguel, JF, Raje, N & Garayoa, M 2014, 'Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease', Clinical Cancer Research, vol. 20, no. 6, pp. 1542-1554. https://doi.org/10.1158/1078-0432.CCR-13-1657

TY - JOUR

T1 - Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease

AU - Garcia-Gomez, A.

AU - Quwaider, D.

AU - Canavese, M.

AU - Ocio, E.M.

AU - Tian, Z.

AU - Blanco, J.F.

AU - Berger, A.J.

AU - Ortiz-de-Solorzano, C.

AU - Hernandez-Iglesias, T.

AU - Martens, A.C.M.

AU - Groen, R.W.J.

AU - Mateo-Urdiales, J.

AU - Fraile, S.

AU - Galarraga, M.

AU - Chauhan, D.

AU - San Miguel, J.F.

AU - Raje, N.

AU - Garayoa, M.

PY - 2014

Y1 - 2014

U2 - 10.1158/1078-0432.CCR-13-1657

DO - 10.1158/1078-0432.CCR-13-1657

M3 - Article

SN - 1078-0432

VL - 20

SP - 1542

EP - 1554

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 6

ER -